Another drug in the pipeline for CLL that is p... - CLL Support
Another drug in the pipeline for CLL that is progressing to trials
You need to be a member of this community to see this post.
Read more about...
11 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Novel Bruton’s Tyrosine Kinase (BTK) inhibitor, ONO-4059 enters UK CLL clinical trial
A new BTK inhibitor enters the fray in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma
Phase I/II trial of IPH2201 checkpoint inhibitor in combination with ibrutinib opens for patients with relapsed or refractory CLL
OPENING-OF-THE-PHASE-I-II-TRIAL-OF-IPH2201-IN-COMBINATION-WITH-IBRUTINIB-IN-PATIENTS-WITH-RELAPSED-O
My TRIP TO NIH for Natural History of CLL Trial
risk CLL patients unless there are symptoms. Not even for the early treatment front line trials....
Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
September 2019
In a phase III trial of patients with previously untreated CLL and...
EHA 2022: Outcomes Following Treatment With a Covalent BTK and BCL2 Inhibitor
-with-a-covalent-btk-and-bcl2-inhibitor-among-patients-with-chronic-lymphocytic-leukemia-cll-small-l
AVO clinical trial for CLL
Cost of CLL Drugs in the USA
Cll Drugs and the Immune System
CLL drugs covered in Ontario
